BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16926039)

  • 1. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells.
    Sadikovic B; Rodenhiser DI
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):458-68. PubMed ID: 16926039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites.
    Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI
    Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.
    Hockley SL; Arlt VM; Brewer D; Giddings I; Phillips DH
    BMC Genomics; 2006 Oct; 7():260. PubMed ID: 17042939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification through microarray gene expression analysis of cellular responses to benzo(a)pyrene and its diol-epoxide that are dependent or independent of p53.
    Hockley SL; Arlt VM; Jahnke G; Hartwig A; Giddings I; Phillips DH
    Carcinogenesis; 2008 Jan; 29(1):202-10. PubMed ID: 17942461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine inhibits cellular growth dependent on the p53 status of cells.
    Benavides MA; Oelschlager DK; Zhang HG; Stockard CR; Vital-Reyes VS; Katkoori VR; Manne U; Wang W; Bland KI; Grizzle WE
    Am J Surg; 2007 Feb; 193(2):274-83. PubMed ID: 17236862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis.
    Huovinen M; Loikkanen J; Myllynen P; Vähäkangas KH
    Toxicol In Vitro; 2011 Aug; 25(5):1007-17. PubMed ID: 21457773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effects on Bcl-2 and p53.
    Formby B; Wiley TS
    Ann Clin Lab Sci; 1998; 28(6):360-9. PubMed ID: 9846203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
    Tampio M; Loikkanen J; Myllynen P; Mertanen A; Vähäkangas KH
    Toxicol Lett; 2008 May; 178(3):152-9. PubMed ID: 18440733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].
    Shen WJ; Dai DQ; Teng Y; Liu J
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen receptor (ER) on benzo[a]pyrene-DNA adduct formation in human breast cancer cells.
    Kang SC; Lee BM
    J Toxicol Environ Health A; 2005 Nov; 68(21):1833-40. PubMed ID: 16207632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
    Song Y; Zhang C
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
    Liu XH; Zheng XF; Wang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Rabi T; Wang L; Banerjee S
    Breast Cancer Res Treat; 2007 Jan; 101(1):27-36. PubMed ID: 17028990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
    Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V
    Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation.
    Chhipa RR; Kumari R; Upadhyay AK; Bhat MK
    Exp Cell Res; 2007 Nov; 313(19):3945-58. PubMed ID: 17935714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gene methylation by genistein or lycopene in breast cancer cells.
    King-Batoon A; Leszczynska JM; Klein CB
    Environ Mol Mutagen; 2008 Jan; 49(1):36-45. PubMed ID: 18181168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.